

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.05205344 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05205344 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66797932 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.58727566 |
| 5 | detection of bacterium (GO:0016045) | 4.27576042 |
| 6 | detection of other organism (GO:0098543) | 4.19268519 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.12601470 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92891758 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.67149696 |
| 10 | response to peptidoglycan (GO:0032494) | 3.65180388 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49011698 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 3.33190151 |
| 13 | regulation of mast cell degranulation (GO:0043304) | 3.31801110 |
| 14 | detection of external biotic stimulus (GO:0098581) | 3.26483463 |
| 15 | positive thymic T cell selection (GO:0045059) | 3.25958448 |
| 16 | B cell receptor signaling pathway (GO:0050853) | 3.25452813 |
| 17 | leukocyte aggregation (GO:0070486) | 3.24040524 |
| 18 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.19903241 |
| 19 | T cell migration (GO:0072678) | 3.16432793 |
| 20 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.13754295 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09362596 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05044795 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04793525 |
| 24 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.04593927 |
| 25 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04236544 |
| 26 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.03322966 |
| 27 | modulation by virus of host process (GO:0019054) | 3.03304317 |
| 28 | respiratory burst (GO:0045730) | 3.01801826 |
| 29 | negative T cell selection (GO:0043383) | 2.98319449 |
| 30 | cellular response to virus (GO:0098586) | 2.97874218 |
| 31 | regulation of leukocyte degranulation (GO:0043300) | 2.96902717 |
| 32 | oxygen transport (GO:0015671) | 2.96408433 |
| 33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.96029918 |
| 34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95502550 |
| 35 | modulation by symbiont of host cellular process (GO:0044068) | 2.95257817 |
| 36 | negative thymic T cell selection (GO:0045060) | 2.94674673 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 2.94430799 |
| 38 | regulation of antigen processing and presentation (GO:0002577) | 2.91754192 |
| 39 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91397474 |
| 40 | response to muramyl dipeptide (GO:0032495) | 2.90321259 |
| 41 | negative regulation of interleukin-12 production (GO:0032695) | 2.90060756 |
| 42 | detection of biotic stimulus (GO:0009595) | 2.86966053 |
| 43 | neutrophil activation (GO:0042119) | 2.84740342 |
| 44 | granulocyte activation (GO:0036230) | 2.82357551 |
| 45 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79777926 |
| 46 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78487658 |
| 47 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76593644 |
| 48 | cysteine metabolic process (GO:0006534) | 2.75537014 |
| 49 | B cell mediated immunity (GO:0019724) | 2.73907835 |
| 50 | hemoglobin metabolic process (GO:0020027) | 2.73574805 |
| 51 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73429605 |
| 52 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73354311 |
| 53 | thymic T cell selection (GO:0045061) | 2.72843203 |
| 54 | regulation of response to interferon-gamma (GO:0060330) | 2.72630268 |
| 55 | positive regulation of humoral immune response (GO:0002922) | 2.72376427 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 2.72144667 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.72144667 |
| 58 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.72144667 |
| 59 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.72144667 |
| 60 | modulation by symbiont of host immune response (GO:0052553) | 2.72144667 |
| 61 | positive regulation by symbiont of host defense response (GO:0052509) | 2.72144667 |
| 62 | germinal center formation (GO:0002467) | 2.70724306 |
| 63 | cellular extravasation (GO:0045123) | 2.70471680 |
| 64 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69738816 |
| 65 | myeloid cell activation involved in immune response (GO:0002275) | 2.69336920 |
| 66 | response to host immune response (GO:0052572) | 2.68270178 |
| 67 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.68270178 |
| 68 | regulation of B cell differentiation (GO:0045577) | 2.67698318 |
| 69 | urea cycle (GO:0000050) | 2.67214934 |
| 70 | urea metabolic process (GO:0019627) | 2.67214934 |
| 71 | immunoglobulin mediated immune response (GO:0016064) | 2.65304898 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64922760 |
| 73 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64480235 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64399348 |
| 75 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.64185812 |
| 76 | citrulline biosynthetic process (GO:0019240) | 2.63786804 |
| 77 | hepatocyte apoptotic process (GO:0097284) | 2.63524225 |
| 78 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.62246411 |
| 79 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.61227360 |
| 80 | L-phenylalanine catabolic process (GO:0006559) | 2.61139708 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.61139708 |
| 82 | indole-containing compound catabolic process (GO:0042436) | 2.59701509 |
| 83 | indolalkylamine catabolic process (GO:0046218) | 2.59701509 |
| 84 | tryptophan catabolic process (GO:0006569) | 2.59701509 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 2.58248797 |
| 86 | aromatic amino acid family catabolic process (GO:0009074) | 2.58042230 |
| 87 | positive regulation of type 2 immune response (GO:0002830) | 2.57437588 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.56926747 |
| 89 | protein-lipid complex assembly (GO:0065005) | 2.56834110 |
| 90 | barbed-end actin filament capping (GO:0051016) | 2.55792754 |
| 91 | negative regulation of innate immune response (GO:0045824) | 2.55783025 |
| 92 | L-phenylalanine metabolic process (GO:0006558) | 2.55706310 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.55706310 |
| 94 | mannose metabolic process (GO:0006013) | 2.55701883 |
| 95 | amino sugar catabolic process (GO:0046348) | 2.55250769 |
| 96 | regulation of necroptotic process (GO:0060544) | 2.54816404 |
| 97 | defense response to protozoan (GO:0042832) | 2.53864496 |
| 98 | response to interleukin-15 (GO:0070672) | 2.52185897 |
| 99 | positive regulation of Rap GTPase activity (GO:0032854) | 2.50896538 |
| 100 | gas transport (GO:0015669) | 2.50498410 |
| 101 | response to type I interferon (GO:0034340) | 2.49687154 |
| 102 | response to host (GO:0075136) | 2.49066691 |
| 103 | response to host defenses (GO:0052200) | 2.49066691 |
| 104 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.49066691 |
| 105 | amyloid precursor protein catabolic process (GO:0042987) | 2.48899642 |
| 106 | phospholipid efflux (GO:0033700) | 2.48789321 |
| 107 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.48143109 |
| 108 | megakaryocyte development (GO:0035855) | 2.47744358 |
| 109 | regulation of regulated secretory pathway (GO:1903305) | 2.47527508 |
| 110 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.47139528 |
| 111 | alpha-linolenic acid metabolic process (GO:0036109) | 2.46136654 |
| 112 | leukocyte degranulation (GO:0043299) | 2.46099629 |
| 113 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.46081200 |
| 114 | positive regulation of antigen processing and presentation (GO:0002579) | 2.45954220 |
| 115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45617433 |
| 116 | positive T cell selection (GO:0043368) | 2.44443444 |
| 117 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44407958 |
| 118 | erythrocyte development (GO:0048821) | 2.44174844 |
| 119 | heme metabolic process (GO:0042168) | 2.42450601 |
| 120 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.42114392 |
| 121 | protein carboxylation (GO:0018214) | 2.42114392 |
| 122 | nitrogen cycle metabolic process (GO:0071941) | 2.41039965 |
| 123 | regulation of platelet aggregation (GO:0090330) | 2.40967069 |
| 124 | macrophage activation (GO:0042116) | 2.40750398 |
| 125 | tryptophan metabolic process (GO:0006568) | 2.39599719 |
| 126 | heme biosynthetic process (GO:0006783) | 2.39481855 |
| 127 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.39168035 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.39130483 |
| 129 | type I interferon signaling pathway (GO:0060337) | 2.39130483 |
| 130 | porphyrin-containing compound metabolic process (GO:0006778) | 2.38721010 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.38267400 |
| 132 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.38022004 |
| 133 | T cell selection (GO:0045058) | 2.37661835 |
| 134 | regulation of cholesterol storage (GO:0010885) | 2.37192534 |
| 135 | tolerance induction (GO:0002507) | 2.33917644 |
| 136 | negative regulation of fibrinolysis (GO:0051918) | 2.33722068 |
| 137 | kynurenine metabolic process (GO:0070189) | 2.33296115 |
| 138 | valine metabolic process (GO:0006573) | 2.32460384 |
| 139 | regulation of T cell tolerance induction (GO:0002664) | 2.31739032 |
| 140 | regulation of superoxide anion generation (GO:0032928) | 2.31617682 |
| 141 | natural killer cell mediated immunity (GO:0002228) | 2.31279847 |
| 142 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.31279847 |
| 143 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.30810697 |
| 144 | complement activation, alternative pathway (GO:0006957) | 2.30771434 |
| 145 | negative regulation of lipid storage (GO:0010888) | 2.30524649 |
| 146 | negative regulation of cell killing (GO:0031342) | 2.30149818 |
| 147 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.30149818 |
| 148 | leukocyte cell-cell adhesion (GO:0007159) | 2.29013616 |
| 149 | lymphocyte costimulation (GO:0031294) | 2.28142338 |
| 150 | regulation of humoral immune response (GO:0002920) | 2.28024084 |
| 151 | T cell costimulation (GO:0031295) | 2.27660616 |
| 152 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.27423916 |
| 153 | pentose-phosphate shunt (GO:0006098) | 2.26834373 |
| 154 | regulation of erythrocyte differentiation (GO:0045646) | 2.26116311 |
| 155 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.24440788 |
| 156 | regulation of RIG-I signaling pathway (GO:0039535) | 2.23822821 |
| 157 | interferon-gamma production (GO:0032609) | 2.23587796 |
| 158 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.22882810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75003445 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.59326901 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.91838530 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81785041 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.81753959 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.79366186 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.78460858 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70885143 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68186620 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.42576811 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.40014925 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.35415943 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.28250064 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.27617979 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26656460 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25396924 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22782841 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22750465 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.18387082 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15224983 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 2.14971941 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08423394 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08396526 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07567949 |
| 25 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.99940753 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92617701 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92539625 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.89846935 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.89111423 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89077845 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.88704522 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83414172 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.82901974 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80108491 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.79859745 |
| 36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77600490 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74999654 |
| 38 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71994264 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.69112542 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68262884 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.68122503 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67125496 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66725598 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65776741 |
| 45 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.65543905 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65401262 |
| 47 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64503639 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64313684 |
| 49 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.62750086 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62033926 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61918526 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.61323357 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61259821 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.59726213 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59238098 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57885208 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55237039 |
| 58 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53566145 |
| 59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.51730197 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49143437 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47899361 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47660352 |
| 63 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.44285880 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43206787 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42191050 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41821720 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40990934 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40358576 |
| 69 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38662708 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38376812 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.37911376 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37513209 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36381962 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36074185 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35555103 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.33318062 |
| 77 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.32229825 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31822269 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31263199 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30191481 |
| 81 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28414169 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27090897 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26920054 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23969852 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23614744 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23530590 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23222543 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22836104 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.21188058 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20745819 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18355009 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16844390 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.13977720 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12254049 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11704560 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11527995 |
| 97 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08173149 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08056370 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06889034 |
| 100 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05838388 |
| 101 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.05735468 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05006753 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04796611 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04218728 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03501815 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03029722 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02998081 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.02650992 |
| 109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02333355 |
| 110 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.02052784 |
| 111 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02024260 |
| 112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01135612 |
| 113 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00771957 |
| 114 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00698118 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00590235 |
| 116 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00564603 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97606106 |
| 118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96489265 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94434561 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94090976 |
| 121 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93713375 |
| 122 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.93584520 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92898548 |
| 124 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92168759 |
| 125 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91347127 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90138187 |
| 127 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.89215564 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89193049 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88652775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.15065130 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 2.83985200 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.72827258 |
| 4 | MP0009840_abnormal_foam_cell | 2.69732125 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.57027925 |
| 6 | MP0000685_abnormal_immune_system | 2.45462519 |
| 7 | MP0003436_decreased_susceptibility_to | 2.39715639 |
| 8 | MP0005671_abnormal_response_to | 2.39644646 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.36664326 |
| 10 | MP0005365_abnormal_bile_salt | 2.33783313 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.24210082 |
| 12 | MP0009785_altered_susceptibility_to | 2.22557306 |
| 13 | MP0003724_increased_susceptibility_to | 2.19446082 |
| 14 | MP0001800_abnormal_humoral_immune | 2.11882848 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.07734916 |
| 16 | MP0001790_abnormal_immune_system | 2.03457056 |
| 17 | MP0005387_immune_system_phenotype | 2.03457056 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 1.97123149 |
| 19 | MP0005025_abnormal_response_to | 1.96989627 |
| 20 | MP0006082_CNS_inflammation | 1.93439940 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 1.91799934 |
| 22 | MP0002452_abnormal_antigen_presenting | 1.90300582 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.90057510 |
| 24 | MP0002723_abnormal_immune_serum | 1.86866344 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.83073290 |
| 26 | MP0001819_abnormal_immune_cell | 1.81762571 |
| 27 | MP0003303_peritoneal_inflammation | 1.81112217 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.80796924 |
| 29 | MP0002419_abnormal_innate_immunity | 1.80744586 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.76170441 |
| 31 | MP0002398_abnormal_bone_marrow | 1.75833454 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.74321541 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.68001222 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.68001222 |
| 35 | MP0004947_skin_inflammation | 1.67187003 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.66778845 |
| 37 | MP0005451_abnormal_body_composition | 1.66587041 |
| 38 | MP0002405_respiratory_system_inflammati | 1.63334880 |
| 39 | MP0005083_abnormal_biliary_tract | 1.61579779 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.57229472 |
| 41 | MP0000716_abnormal_immune_system | 1.57143710 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.49747036 |
| 43 | MP0002722_abnormal_immune_system | 1.49122388 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.47237358 |
| 45 | MP0003252_abnormal_bile_duct | 1.45938802 |
| 46 | MP0000609_abnormal_liver_physiology | 1.44324387 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.43759582 |
| 48 | MP0008469_abnormal_protein_level | 1.41741897 |
| 49 | MP0009764_decreased_sensitivity_to | 1.40309364 |
| 50 | MP0002429_abnormal_blood_cell | 1.40302282 |
| 51 | MP0004510_myositis | 1.39403254 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.39104502 |
| 53 | MP0001873_stomach_inflammation | 1.38841653 |
| 54 | MP0005310_abnormal_salivary_gland | 1.38637136 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.38554229 |
| 56 | MP0003075_altered_response_to | 1.33990575 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.33011662 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.32590941 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.27061925 |
| 60 | MP0002006_tumorigenesis | 1.23969766 |
| 61 | MP0005075_abnormal_melanosome_morpholog | 1.22833360 |
| 62 | MP0000858_altered_metastatic_potential | 1.19807954 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.19378442 |
| 64 | MP0003828_pulmonary_edema | 1.19266408 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.13878058 |
| 66 | MP0002132_abnormal_respiratory_system | 1.12421700 |
| 67 | MP0002933_joint_inflammation | 1.11270813 |
| 68 | MP0000490_abnormal_crypts_of | 1.10490256 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.10027244 |
| 70 | MP0000703_abnormal_thymus_morphology | 1.08650660 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.06157937 |
| 72 | MP0009278_abnormal_bone_marrow | 1.05356096 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.05185298 |
| 74 | MP0009763_increased_sensitivity_to | 1.02501216 |
| 75 | MP0001853_heart_inflammation | 0.99342483 |
| 76 | MP0005166_decreased_susceptibility_to | 0.97877717 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 0.97841485 |
| 78 | MP0003448_altered_tumor_morphology | 0.97401900 |
| 79 | MP0009643_abnormal_urine_homeostasis | 0.96837459 |
| 80 | MP0000604_amyloidosis | 0.96738815 |
| 81 | MP0001849_ear_inflammation | 0.96212180 |
| 82 | MP0000343_altered_response_to | 0.95635074 |
| 83 | MP0003705_abnormal_hypodermis_morpholog | 0.93086850 |
| 84 | MP0001663_abnormal_digestive_system | 0.92808424 |
| 85 | MP0000598_abnormal_liver_morphology | 0.92131219 |
| 86 | MP0008260_abnormal_autophagy | 0.91787519 |
| 87 | MP0002822_catalepsy | 0.90595149 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 0.89891229 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.89233180 |
| 90 | MP0003186_abnormal_redox_activity | 0.89101778 |
| 91 | MP0005332_abnormal_amino_acid | 0.88316504 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.88023933 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.86703585 |
| 94 | MP0003693_abnormal_embryo_hatching | 0.85612271 |
| 95 | MP0006054_spinal_hemorrhage | 0.83801747 |
| 96 | MP0008874_decreased_physiological_sensi | 0.83220211 |
| 97 | MP0005023_abnormal_wound_healing | 0.82218242 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.82137021 |
| 99 | MP0003329_amyloid_beta_deposits | 0.81016287 |
| 100 | MP0008004_abnormal_stomach_pH | 0.80850177 |
| 101 | MP0005666_abnormal_adipose_tissue | 0.80652392 |
| 102 | MP0004381_abnormal_hair_follicle | 0.80529672 |
| 103 | MP0003866_abnormal_defecation | 0.79971236 |
| 104 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77605570 |
| 105 | MP0004858_abnormal_nervous_system | 0.77592759 |
| 106 | MP0003172_abnormal_lysosome_physiology | 0.75343459 |
| 107 | MP0000249_abnormal_blood_vessel | 0.74775158 |
| 108 | MP0005408_hypopigmentation | 0.73092677 |
| 109 | MP0005390_skeleton_phenotype | 0.72203607 |
| 110 | MP0003011_delayed_dark_adaptation | 0.72107541 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.71725688 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.71231529 |
| 113 | MP0004147_increased_porphyrin_level | 0.71006881 |
| 114 | MP0001851_eye_inflammation | 0.70826704 |
| 115 | MP0003690_abnormal_glial_cell | 0.70531593 |
| 116 | MP0003795_abnormal_bone_structure | 0.69609569 |
| 117 | MP0001243_abnormal_dermal_layer | 0.69607395 |
| 118 | MP0004019_abnormal_vitamin_homeostasis | 0.69492244 |
| 119 | MP0001764_abnormal_homeostasis | 0.69436067 |
| 120 | MP0003806_abnormal_nucleotide_metabolis | 0.67054360 |
| 121 | MP0009931_abnormal_skin_appearance | 0.66575487 |
| 122 | MP0003879_abnormal_hair_cell | 0.66447267 |
| 123 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66233335 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.62509473 |
| 125 | MP0005670_abnormal_white_adipose | 0.60705427 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.59216832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.80346050 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.63716679 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.58917855 |
| 4 | Autoimmune thrombocytopenia (HP:0001973) | 3.46868476 |
| 5 | Petechiae (HP:0000967) | 3.42057166 |
| 6 | Poikilocytosis (HP:0004447) | 3.36221778 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.35965731 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.28862743 |
| 9 | Pustule (HP:0200039) | 3.25013228 |
| 10 | Nasal polyposis (HP:0100582) | 3.23793372 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.23221455 |
| 12 | Myocardial infarction (HP:0001658) | 3.18030136 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.17417666 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.14116995 |
| 15 | Chronic otitis media (HP:0000389) | 3.07865345 |
| 16 | Orchitis (HP:0100796) | 3.07773336 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.06769067 |
| 18 | Abnormal platelet function (HP:0011869) | 3.02585312 |
| 19 | Impaired platelet aggregation (HP:0003540) | 3.02585312 |
| 20 | Recurrent viral infections (HP:0004429) | 3.02398186 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.00111529 |
| 22 | Recurrent skin infections (HP:0001581) | 2.99865121 |
| 23 | Xanthomatosis (HP:0000991) | 2.93662282 |
| 24 | Gingival bleeding (HP:0000225) | 2.93173873 |
| 25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.92618244 |
| 26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.92618244 |
| 27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.92618244 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.87032008 |
| 29 | Prolonged bleeding time (HP:0003010) | 2.86999968 |
| 30 | Combined immunodeficiency (HP:0005387) | 2.86732627 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.84122750 |
| 32 | Epistaxis (HP:0000421) | 2.84014354 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.82939765 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81768516 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81768516 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.80780512 |
| 37 | Joint hemorrhage (HP:0005261) | 2.76862322 |
| 38 | Severe combined immunodeficiency (HP:0004430) | 2.73911689 |
| 39 | Hypochromic anemia (HP:0001931) | 2.73518544 |
| 40 | Tetraparesis (HP:0002273) | 2.71207480 |
| 41 | Hyperlipoproteinemia (HP:0010980) | 2.70536565 |
| 42 | Acanthocytosis (HP:0001927) | 2.69185924 |
| 43 | Polycythemia (HP:0001901) | 2.66835425 |
| 44 | T lymphocytopenia (HP:0005403) | 2.66427589 |
| 45 | Abnormality of T cell number (HP:0011839) | 2.61637858 |
| 46 | Hypertensive crisis (HP:0100735) | 2.59518940 |
| 47 | Optic neuritis (HP:0100653) | 2.58196403 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.58196403 |
| 49 | Gastrointestinal stroma tumor (HP:0100723) | 2.55648203 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.54596726 |
| 51 | Myositis (HP:0100614) | 2.52067780 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.51292735 |
| 53 | Increased serum ferritin (HP:0003281) | 2.50763928 |
| 54 | Abnormality of T cells (HP:0002843) | 2.50526994 |
| 55 | Gingivitis (HP:0000230) | 2.50422164 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.50073757 |
| 57 | IgM deficiency (HP:0002850) | 2.49088449 |
| 58 | Encephalitis (HP:0002383) | 2.48989925 |
| 59 | Microcytic anemia (HP:0001935) | 2.47829562 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.47698633 |
| 61 | Complement deficiency (HP:0004431) | 2.46954982 |
| 62 | Leukocytosis (HP:0001974) | 2.46635538 |
| 63 | Prolonged partial thromboplastin time (HP:0003645) | 2.46005152 |
| 64 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.45144085 |
| 65 | Loss of speech (HP:0002371) | 2.43394436 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41734663 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.41522693 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.40316410 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.39569044 |
| 70 | Chest pain (HP:0100749) | 2.39477744 |
| 71 | Cholecystitis (HP:0001082) | 2.37333916 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.37333916 |
| 73 | Purpura (HP:0000979) | 2.36741156 |
| 74 | Agammaglobulinemia (HP:0004432) | 2.35853422 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.35359252 |
| 76 | Increased IgM level (HP:0003496) | 2.33306576 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.33290261 |
| 78 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.30682134 |
| 79 | Osteomyelitis (HP:0002754) | 2.30419651 |
| 80 | Menorrhagia (HP:0000132) | 2.29887714 |
| 81 | Cellulitis (HP:0100658) | 2.29777112 |
| 82 | Pulmonary infiltrates (HP:0002113) | 2.29499484 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.29063080 |
| 84 | Increased IgE level (HP:0003212) | 2.29049263 |
| 85 | Abnormality of complement system (HP:0005339) | 2.28816033 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.28660386 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.25487183 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.25394190 |
| 89 | Thrombocytosis (HP:0001894) | 2.24805929 |
| 90 | Vasculitis (HP:0002633) | 2.23471310 |
| 91 | Amyloidosis (HP:0011034) | 2.23125874 |
| 92 | Meningitis (HP:0001287) | 2.22691099 |
| 93 | Stomatitis (HP:0010280) | 2.22079458 |
| 94 | Abnormality of the common coagulation pathway (HP:0010990) | 2.20293742 |
| 95 | Colitis (HP:0002583) | 2.19506358 |
| 96 | Hyperbilirubinemia (HP:0002904) | 2.15895705 |
| 97 | Abnormal platelet volume (HP:0011876) | 2.13998814 |
| 98 | Thoracic kyphosis (HP:0002942) | 2.12924707 |
| 99 | IgG deficiency (HP:0004315) | 2.12739713 |
| 100 | Hemorrhage of the eye (HP:0011885) | 2.12658183 |
| 101 | Abnormal hemoglobin (HP:0011902) | 2.12568735 |
| 102 | Obstructive lung disease (HP:0006536) | 2.11897949 |
| 103 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11897949 |
| 104 | Hypergammaglobulinemia (HP:0010702) | 2.10834300 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09923070 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09689471 |
| 107 | Cholelithiasis (HP:0001081) | 2.08478056 |
| 108 | Reticulocytosis (HP:0001923) | 2.07447592 |
| 109 | Glomerulonephritis (HP:0000099) | 2.07001326 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.06723336 |
| 111 | Lymphopenia (HP:0001888) | 2.06087013 |
| 112 | Urticaria (HP:0001025) | 2.05639485 |
| 113 | Intrahepatic cholestasis (HP:0001406) | 2.05416694 |
| 114 | Eosinophilia (HP:0001880) | 2.03216746 |
| 115 | Fatigue (HP:0012378) | 2.02990685 |
| 116 | Abnormality of the fingertips (HP:0001211) | 2.02327470 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01099378 |
| 118 | Papilloma (HP:0012740) | 2.00218259 |
| 119 | Verrucae (HP:0200043) | 2.00218259 |
| 120 | Sepsis (HP:0100806) | 1.99511183 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.99115899 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.99072989 |
| 123 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.97958647 |
| 124 | Granulocytopenia (HP:0001913) | 1.97943171 |
| 125 | Thyroiditis (HP:0100646) | 1.97390236 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.97011629 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96864875 |
| 128 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96864875 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96864875 |
| 130 | Episodic fever (HP:0001954) | 1.96558888 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96226865 |
| 132 | Periodontitis (HP:0000704) | 1.96005474 |
| 133 | Mitral stenosis (HP:0001718) | 1.95563429 |
| 134 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95140897 |
| 135 | Mucopolysacchariduria (HP:0008155) | 1.95140897 |
| 136 | Restrictive lung disease (HP:0002091) | 1.94400707 |
| 137 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94204895 |
| 138 | Slow saccadic eye movements (HP:0000514) | 1.90409541 |
| 139 | Hypertriglyceridemia (HP:0002155) | 1.86734517 |
| 140 | Skin rash (HP:0000988) | 1.84795213 |
| 141 | Emphysema (HP:0002097) | 1.84533396 |
| 142 | Hemoptysis (HP:0002105) | 1.83319468 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.82896703 |
| 144 | Increased connective tissue (HP:0009025) | 1.81458009 |
| 145 | Vertebral compression fractures (HP:0002953) | 1.80638976 |
| 146 | Distal lower limb muscle weakness (HP:0009053) | 1.78615551 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.77532562 |
| 2 | PRPF4B | 3.37698944 |
| 3 | ERN1 | 3.14312221 |
| 4 | RIPK4 | 2.95986936 |
| 5 | TAOK3 | 2.85263645 |
| 6 | TYK2 | 2.50453252 |
| 7 | EEF2K | 2.42034490 |
| 8 | TBK1 | 2.41817149 |
| 9 | ZAP70 | 2.34442266 |
| 10 | FGFR4 | 2.30882923 |
| 11 | IKBKE | 2.30602367 |
| 12 | TXK | 2.28617601 |
| 13 | TAOK2 | 2.24770402 |
| 14 | NME2 | 2.10576934 |
| 15 | STK10 | 2.09374695 |
| 16 | BLK | 2.08020435 |
| 17 | TRIB3 | 2.07328449 |
| 18 | EIF2AK1 | 2.03491723 |
| 19 | IRAK4 | 1.94974229 |
| 20 | JAK3 | 1.93899120 |
| 21 | TGFBR2 | 1.82240886 |
| 22 | SMG1 | 1.75547263 |
| 23 | TNK2 | 1.71398974 |
| 24 | BTK | 1.69779185 |
| 25 | JAK1 | 1.60724449 |
| 26 | MAP3K14 | 1.59371584 |
| 27 | MAP3K10 | 1.58626403 |
| 28 | NLK | 1.51972541 |
| 29 | TESK2 | 1.46956866 |
| 30 | EPHB1 | 1.46136500 |
| 31 | PIM2 | 1.44778539 |
| 32 | IRAK3 | 1.44345645 |
| 33 | IKBKB | 1.44189826 |
| 34 | MAP3K1 | 1.42493123 |
| 35 | RPS6KA4 | 1.42284433 |
| 36 | TEC | 1.36927481 |
| 37 | FES | 1.36720366 |
| 38 | PIM1 | 1.34136526 |
| 39 | LRRK2 | 1.34015810 |
| 40 | ITK | 1.29410125 |
| 41 | KDR | 1.28307166 |
| 42 | SIK1 | 1.24895310 |
| 43 | TESK1 | 1.24589661 |
| 44 | SYK | 1.24533495 |
| 45 | GRK6 | 1.22948140 |
| 46 | HCK | 1.21339802 |
| 47 | KIT | 1.20331365 |
| 48 | EPHA3 | 1.15925390 |
| 49 | JAK2 | 1.15659424 |
| 50 | MARK2 | 1.10451025 |
| 51 | MAP3K6 | 1.08565325 |
| 52 | PKN2 | 1.07876644 |
| 53 | CSK | 1.03470291 |
| 54 | NEK9 | 1.02426452 |
| 55 | KSR2 | 1.01546192 |
| 56 | RIPK1 | 1.01320317 |
| 57 | LCK | 1.00418461 |
| 58 | ARAF | 0.97864550 |
| 59 | CHUK | 0.96402372 |
| 60 | FGR | 0.96073557 |
| 61 | ICK | 0.94992420 |
| 62 | DYRK1B | 0.93508505 |
| 63 | MAPK12 | 0.93000148 |
| 64 | CSF1R | 0.91932106 |
| 65 | TAOK1 | 0.91487228 |
| 66 | MAPK11 | 0.90399040 |
| 67 | BUB1 | 0.90143051 |
| 68 | MAPKAPK3 | 0.89287900 |
| 69 | MAP2K3 | 0.88089378 |
| 70 | BCKDK | 0.87731206 |
| 71 | STK4 | 0.86248348 |
| 72 | LYN | 0.83890907 |
| 73 | STK3 | 0.83666387 |
| 74 | MATK | 0.82952373 |
| 75 | MAP3K3 | 0.82237621 |
| 76 | CDK6 | 0.79582392 |
| 77 | NEK2 | 0.78802644 |
| 78 | PDPK1 | 0.76085149 |
| 79 | RPS6KL1 | 0.73095730 |
| 80 | RPS6KC1 | 0.73095730 |
| 81 | IRAK2 | 0.72667618 |
| 82 | CDK9 | 0.72605702 |
| 83 | CDC42BPA | 0.71632490 |
| 84 | PRKD2 | 0.70047030 |
| 85 | RPS6KA2 | 0.69690723 |
| 86 | FGFR3 | 0.69413450 |
| 87 | MOS | 0.66470151 |
| 88 | PDK1 | 0.66259317 |
| 89 | CDK4 | 0.65514729 |
| 90 | PTK6 | 0.64646800 |
| 91 | LATS1 | 0.64012310 |
| 92 | IRAK1 | 0.63243193 |
| 93 | MST4 | 0.61835273 |
| 94 | TRPM7 | 0.61725728 |
| 95 | STK24 | 0.61112232 |
| 96 | ABL1 | 0.60410879 |
| 97 | DYRK3 | 0.58860567 |
| 98 | MAPK4 | 0.55724274 |
| 99 | TTN | 0.55164154 |
| 100 | MAP2K2 | 0.55161524 |
| 101 | MAPK7 | 0.55156709 |
| 102 | MARK3 | 0.54269327 |
| 103 | HIPK2 | 0.50928067 |
| 104 | MAP3K13 | 0.49609541 |
| 105 | MAPKAPK2 | 0.49352722 |
| 106 | CDK12 | 0.49112455 |
| 107 | FLT3 | 0.48457612 |
| 108 | ACVR1B | 0.47527585 |
| 109 | ABL2 | 0.47308091 |
| 110 | SIK2 | 0.46782178 |
| 111 | FYN | 0.45518510 |
| 112 | MAP2K6 | 0.44759523 |
| 113 | MAP3K8 | 0.44322373 |
| 114 | PRKAA2 | 0.42060898 |
| 115 | CLK1 | 0.40877802 |
| 116 | PRKCQ | 0.39435250 |
| 117 | BRAF | 0.38084682 |
| 118 | TLK1 | 0.37573267 |
| 119 | MAP3K5 | 0.37493387 |
| 120 | TIE1 | 0.37431456 |
| 121 | CAMKK1 | 0.37357816 |
| 122 | SIK3 | 0.37046021 |
| 123 | PRKD1 | 0.36027058 |
| 124 | MAP3K7 | 0.34839114 |
| 125 | SGK3 | 0.34410973 |
| 126 | RPS6KA6 | 0.33764460 |
| 127 | STK38 | 0.33293318 |
| 128 | BMPR2 | 0.32841588 |
| 129 | ERBB4 | 0.32397650 |
| 130 | MAP3K11 | 0.31758523 |
| 131 | BMX | 0.31480707 |
| 132 | PAK4 | 0.30766997 |
| 133 | RET | 0.30261866 |
| 134 | RPS6KB2 | 0.27839234 |
| 135 | PDGFRB | 0.27197378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65830337 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43999199 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34125861 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28133467 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.25581276 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05684813 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.87347162 |
| 8 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77938865 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76249223 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.74845568 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73144280 |
| 12 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.73059054 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.68550516 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.66957020 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.64634341 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63793066 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61056739 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50309446 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.50185773 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.50162345 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46601078 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45573067 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45465354 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36131667 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.35231855 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.35139203 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31894881 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.30022624 |
| 29 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25651670 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25433238 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24664093 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24030993 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.23293187 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22663954 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21848004 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20235209 |
| 37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18776302 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.16372020 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15467873 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.14788029 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14317187 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.12936478 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12665052 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12572746 |
| 45 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11799398 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10025350 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09902292 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08471634 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05559133 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05447498 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03857826 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03561178 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03335086 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.02754967 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02714713 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.01969617 |
| 57 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01537388 |
| 58 | Malaria_Homo sapiens_hsa05144 | 1.00857127 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.99865596 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97990396 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.96978683 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94725993 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94567326 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.91153341 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90845720 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90006812 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89612359 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.89393055 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88800398 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.86645178 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.85365171 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.85152168 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.84627287 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84136382 |
| 75 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84132474 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83894183 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83710113 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.83216820 |
| 79 | Legionellosis_Homo sapiens_hsa05134 | 0.83104938 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82874355 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81579429 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.80332272 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79585235 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77160653 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73721020 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71235446 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71136262 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71130827 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.71109620 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.70839660 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70774143 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69589622 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68819649 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68784853 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68664288 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64924689 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64653309 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64485147 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64048447 |
| 100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64037396 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63185915 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62990631 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62720627 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62150664 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60642685 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60156455 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59636822 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.59588005 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.59223523 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59129761 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58612210 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58564400 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58426829 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58267798 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58153943 |
| 116 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58034926 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55442762 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55215687 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54703706 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53788339 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52808225 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52574727 |
| 123 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52404246 |
| 124 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51912745 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51749835 |
| 126 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.51576802 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49720042 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49710172 |
| 129 | Platelet activation_Homo sapiens_hsa04611 | 0.49344028 |
| 130 | Bladder cancer_Homo sapiens_hsa05219 | 0.49191230 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.48240120 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47071252 |
| 133 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46494962 |
| 134 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45165622 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45108575 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44244064 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.43924863 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43251689 |
| 139 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42824993 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41268001 |
| 141 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40692467 |

